Google TrendMONTEZ SWEAT (1000+) — Bears DE Montez Sweat suspended 2 days for drug violation
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Breast Cancer Survival No" (30 stories)

Top Headline Story

Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival
Lead StoryUT MD Andersongeneral
5d ago

Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival

<a href="https://news.google.com/rss/articles/CBMilAJBVV95cUxPU2NqdWMzN3laV3hTUW9UbmlOT1ltXzI2MFdGT2V2MUFiU2h1T01Xb1JaZVNIME1adHR5cG05ZlY2T0doMlhEZmUtbnpUbERUTHRSSlRZLXMyaXNzVmVWN2U4TGdhU3dtam1WRlBfMHZCUUdvRGItY3kxSjNUNXYxSjU5QkRaZlNzck14aVU3WEtIVzZSUUhFdDA3aFBTbXlOdFI0ZXhTa3RYbVlBams4VENNdzlzbnJ1MWpOdEp6X3BaeXZ6RFAyUEdKZjVjWW50QzN5MEoyeHNrYzRCbmx6bnhPeWVRY29LRS15Y0FhaXlLQkUwUVQ0Z3pHMzNLY3FteFM1YlBpZHUxNkdBQWRKN1ZfSDQ?oc=5" target="_blank">Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival</a>  <font color="#6f6f6f">UT MD Anderson</font>

Real-time search volume
1000+16m ago

montez sweat

Bears DE Montez Sweat suspended 2 days for drug violation

1000+26m ago

rob lowe

Daily Wire's 'Confession': Details Revealed For James Franco, Rob Lowe Film

500+26m ago

tanner hudson

Bengals tight end Tanner Hudson out for season with torn pec

200+26m ago

frozen frenzy

The top reason to watch every NHL team in the Frozen Frenzy

Search Results for "Breast Cancer Survival No"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Triple-Negative Breast Cancer Prognosis, Survival, and Recurrence
Breast Cancer.orggeneral

Triple-Negative Breast Cancer Prognosis, Survival, and Recurrence

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBoT1hIZlNVREFKUi1fcjQ4ZGdrZlh5b2RPRjhJRTE3bWV3dGJ2NXhVTm9UTlVBRzgxb0ZMenRMU3NoOER4M3l6VVcxY3FITmY2dWUtTUE3eXNtWkQ4SFU0M0RERDlsdkRmVzB0WQ?oc=5" target="_blank">Triple-Negative Breast Cancer Prognosis, Survival, and Recurrence</a>  <font color="#6f6f6f">Breast Cancer.org</font>

No Man’s Land: When Metastatic Breast Cancer Responds Long-Term
Cure Todaygeneral

No Man’s Land: When Metastatic Breast Cancer Responds Long-Term

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQSzVRQndoQ2o0UGMwd200VWhHQmtMQmpZRVEzU1B1UV9pSHY3YmM3YTRINVh1VjF0YnZ4d2VDNUxRWThCM2xrWERNYU5uTmtXRlY1Z0tOZzNiQUdmX3lZN18wdUx3X3Rpd2xCU1hMQ0ZUNzhRb1g2eW95aDVUdUpWMzZ6dUVhTURqYmg2cWtyMXhVemJTdnJKVA?oc=5" target="_blank">No Man’s Land: When Metastatic Breast Cancer Responds Long-Term</a>  <font color="#6f6f6f">Cure Today</font>

Breast cancer is not a death sentence – survivor Patricia Essel urges early detection
Asaase Radiogeneral

Breast cancer is not a death sentence – survivor Patricia Essel urges early detection

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQSzhzVHVwemwwS3RzYUdKWmgtbEhRaTNESzZNMGxrd1BkZGZzT3dYMWN4ZklOSWh1SUtSZHB5clBYakF0MUoxTDlzYkdNN0VJZ1k1Y1p3X0lXbFhZalNJYnFoTnBqdGRiTHhXZUFjekZSUkJySjZkYjlMeGdocGUzM05iS29WRVkwaGQtUmZ3QnZ5NXU5NjRWVlM5RG1qT2dvMUlhZldNWnNDaVFv?oc=5" target="_blank">Breast cancer is not a death sentence – survivor Patricia Essel urges early detection</a>  <font color="#6f6f6f">Asaase Radio</font>

Global breast cancer survival estimates in 2017–2021 to advance the WHO Global Breast Cancer Initiative
Naturegeneral

Global breast cancer survival estimates in 2017–2021 to advance the WHO Global Breast Cancer Initiative

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqb0VJX2NaQ24ySEZVVGxYTGFMOWpEY1RCVTdLNmhyOFdMU0N3d1BiWGxKM2Z0al9XM3V4Rm44OTVhQ0tHTmdhRGRNNEEtbkZzNmVGUXIzSm9aZHBjZVFN?oc=5" target="_blank">Global breast cancer survival estimates in 2017–2021 to advance the WHO Global Breast Cancer Initiative</a>  <font color="#6f6f6f">Nature</font>

UAE women on fighting breast cancer and reclaiming their lives: ‘I'm not going anywhere'
Gulf Newstech

UAE women on fighting breast cancer and reclaiming their lives: ‘I'm not going anywhere'

<a href="https://news.google.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?oc=5" target="_blank">UAE women on fighting breast cancer and reclaiming their lives: ‘I'm not going anywhere'</a>  <font color="#6f6f6f">Gulf News</font>

Node-Negative Breast Cancer: 20-Year Outcomes With IM-MS Lymph Node Irradiation
The ASCO Postgeneral

Node-Negative Breast Cancer: 20-Year Outcomes With IM-MS Lymph Node Irradiation

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPN3lYTU9sY0JWSHNDR0d4UnR5dHFQbHFKdTJVMFVKYk92eVR0N3Y0ODljMTc3VEQ1ekRXQWEwdXlreV9qV1AtZlJvbW1pSDdqNXlYX29sVDNreXBqV1VyanVYOXp1TjFOYnlQMzJMS3V4Y280Tkx2MFdPTFotWTV4S0hSMHdsQURPaTViM21Ha3FwZ3hLSWFZYjFjRURxLWNCa0hzN0lJelhSVEk3RTBGa2swWHZJQQ?oc=5" target="_blank">Node-Negative Breast Cancer: 20-Year Outcomes With IM-MS Lymph Node Irradiation</a>  <font color="#6f6f6f">The ASCO Post</font>

‘Too Good to Be True?’ GLP-1s and Breast Cancer Survival
Medscapegeneral

‘Too Good to Be True?’ GLP-1s and Breast Cancer Survival

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQSS1UbVJjaGpCQ01oeTVkcWdCX3dPUFU2V1k2Njg1SklUeEVoOTZXSnRqTllycGFHWjZldGJ3d2lkZjN3SHhjNU9md2tFd18yd3NJTXRuV3VaR2dmTTc2WHJwLWtoUTNmR3R3OUZfTVBlcVh6aGNTcTdhWXdjR3NoRkhmWkpuM0Nqb2lPSF9nakc4Q3FwV3pBeWdpMzAzWnRaN1E?oc=5" target="_blank">‘Too Good to Be True?’ GLP-1s and Breast Cancer Survival</a>  <font color="#6f6f6f">Medscape</font>

No Survival Advantage for Risk-Reducing Mastectomy Over Surveillance in BRCA1/2 Carriers
Targeted Oncologygeneral

No Survival Advantage for Risk-Reducing Mastectomy Over Surveillance in BRCA1/2 Carriers

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNUktRRmZzMV9NZUVkRUF6QlNqUnVSbF9HNVNlSTF0a0Y3YWs5SllhZzZEWmoyRm1XZHpzVVhKTU1JRndQZGZSMTNNc0ItaGRXNldnU1JBWTlleHpIaVZPQVZMSmRrdkY3OG5ocDYxc2hoQnlwWGFaeGJDM0JaY01JV19JbTY2OUNkMmtBZC1MYTZXaGcyakY4c084d25IUlFnQ0xFa0FUQUtLYmxuLVRITVZPUUNVS1dTRktlYVNn?oc=5" target="_blank">No Survival Advantage for Risk-Reducing Mastectomy Over Surveillance in BRCA1/2 Carriers</a>  <font color="#6f6f6f">Targeted Oncology</font>

What Is the Survival Rate of Stage 4 (Metastatic) Breast Cancer?
Health.comgeneral

What Is the Survival Rate of Stage 4 (Metastatic) Breast Cancer?

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNUmttbGItWEhXRVM0VTA0ODZrTDZWcVNuRGR1QmpqbHRJNjZRMjA4eTFQZS1MNVg4SFM1SU1xVGhMalhHeGJRQnRuRW9ZaHBDcU1HOWx3U3FsSjJRa29ybjE1bVM4ZDBHcEdCbTQtQ2VjMnVHQXRyZnprNkFuVDdXRHhkbXZKZ3c1M2dNOERR?oc=5" target="_blank">What Is the Survival Rate of Stage 4 (Metastatic) Breast Cancer?</a>  <font color="#6f6f6f">Health.com</font>

What You Need to Know About Triple-Negative Breast Cancer With Chemo Resistance
Verywell Healthgeneral

What You Need to Know About Triple-Negative Breast Cancer With Chemo Resistance

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNVXMyV2doek8xaU5oUDQ0R2xTTkRaV01xdFJBNmU0ZUJ4bDhfRXBWM0o3aDVUcWdQM2xzd0JOMFVwZkFyaXpzb2U0ZnVyN0QyUFBGdmtSdTFuY25hbzMxbzZHeENwU3paQW9QWFhCSnJqNnNzbnVQSDZFWEY5WXc2X2dhZFZkVEVrTlBvOUlwVUZHUVd3VnlF?oc=5" target="_blank">What You Need to Know About Triple-Negative Breast Cancer With Chemo Resistance</a>  <font color="#6f6f6f">Verywell Health</font>

Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates
AstraZenecageneral

Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPWEpYdWUtelUxSkhNVTdFaDZKdUxlRUt4OXVlTnZNNFNHODFqMmxWbkZWcHpBVzhuU3ViUFEySHJaa29SMnRzeThZdDA1LXhVLW13OXhORU05R2cyaE5wbFZxbkF6NmQ0RWdzcmx0SWRyQnpuMGtfWjRtR29ZM3l3dTUyZDgyQ2VpQk5uZExpUkFZdmd3blR1YWlfblg2OFhnTVhZU0dfR0VuMGpaeGlJUGVxR0VnUQ?oc=5" target="_blank">Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates</a>  <font color="#6f6f6f">AstraZeneca</font>

Occult Breast Cancer Presenting as Axillary Lymphadenopathy: A Case Report
Cureusgeneral

Occult Breast Cancer Presenting as Axillary Lymphadenopathy: A Case Report

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQTEpYcTRKZ0w4VjB4aE84WU9fZ1d2Y3pVbWpPOFJ6cHBLWkdpdWVOLTRGZ0hKNUFXcUNuaFlyNUd4b2Iyc3Y4THFQY2FXRElkZHQxUzlPTURTMzIxZE5fRXcyY280cGNIWEoxNHd3MW92bTY5OGtGaUNoaWttQjN2eGNQQkVvMWlyclhWODA0bS1PUTlVVDdEM21PRU9ucU1lOXF2Q01MUGlSN0dHTklOWE5B?oc=5" target="_blank">Occult Breast Cancer Presenting as Axillary Lymphadenopathy: A Case Report</a>  <font color="#6f6f6f">Cureus</font>

Keytruda Boosts Seven-Year Survival in Triple-Negative Breast Cancer
Cure Todaygeneral

Keytruda Boosts Seven-Year Survival in Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQaXA0VUNNM2tDVW9hTWhlb2RtUzl3MTdkN0UtTVhPV242bEJoTFdIUGVvVGxJMk5DS0p4cmlFbVVnbFNKcWJBSGJSMkwxVDFEMUtjQl9nLUo2ZXEwM0czUGI2MV91blFtQ2RGTjNnY3dzTGttYlhGa2JTY1d2dTdmMHVPWkdTaHgyT0NoQ0VFRWhFYjVraVhvSGo0ZDR6QzQy?oc=5" target="_blank">Keytruda Boosts Seven-Year Survival in Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">Cure Today</font>

Anti-Nausea Drug During Chemo Boosts Breast Cancer Survival
Breast Cancer.orggeneral

Anti-Nausea Drug During Chemo Boosts Breast Cancer Survival

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5MZUhYNXcwcnE0akdaaTlJUW1DbW1icU4yeVB6ekVSUHVvZWloSGZNT0xxWDhITFliZk1mcS1XRWtJbzB0aEllX1FoN1B0eW00cGZadi1DTUYxUlNKOWt3U3k1ZjE0N2dvWFo0?oc=5" target="_blank">Anti-Nausea Drug During Chemo Boosts Breast Cancer Survival</a>  <font color="#6f6f6f">Breast Cancer.org</font>

Trimester of diagnosis affects tumor characteristics and survival in breast cancer during pregnancy: first results from the STURGATE collaboration | npj Breast Cancer
Naturegeneral

Trimester of diagnosis affects tumor characteristics and survival in breast cancer during pregnancy: first results from the STURGATE collaboration | npj Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5iLTR5Q0xpY0RoX1pETmFSaGl3akpMUGRGb0JyS3paQzNoX2xLb0RveEQ2dnRwNXpIOVd4MlhqSVlMSUxYQkpFTTlwNVNDVUFpcE80eHQybk55bV9DZHpr?oc=5" target="_blank">Trimester of diagnosis affects tumor characteristics and survival in breast cancer during pregnancy: first results from the STURGATE collaboration | npj Breast Cancer</a>  <font color="#6f6f6f">Nature</font>

5 New Findings About GLP-1s and Breast Cancer
Breast Cancer.orggeneral

5 New Findings About GLP-1s and Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WNGtkLV92LTdaZHUyemF6TFNpN2diUHZLUUpvanB2R1RyLWdBX1A2RVY1Y2Z6c3N5NW5kcGdZdmdKSThhcnFnanBaQ2xXdHRYb3hCOXIwNDR3SnN6M1FKUGlmSm1qdw?oc=5" target="_blank">5 New Findings About GLP-1s and Breast Cancer</a>  <font color="#6f6f6f">Breast Cancer.org</font>

Living Beyond Stage 4: Finding Hope Amidst Metastatic Breast Cancer
Cure Todaygeneral

Living Beyond Stage 4: Finding Hope Amidst Metastatic Breast Cancer

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQNE9sajJON0VfU2h3OWRFYzViQ1M5ZFdmUklYVjB5bzF5UTVqd1FtaXBMWVlHLUxWVkdhR1poUV9wZ2JPbnpJRWN5VVpZZEsxV1JlMWphcWhWcEJfalN2TGFaa0hMYmFTY1lINktUUTZMNnRXVGw3Y0hNWDgwakZVZ09mejZkVl9tMEcyU19kV1RGSEkyNDQwcjQySGhKUQ?oc=5" target="_blank">Living Beyond Stage 4: Finding Hope Amidst Metastatic Breast Cancer</a>  <font color="#6f6f6f">Cure Today</font>

Factors determining survival in oligometastatic breast cancer in a retrospective cohort study from a low and middle income country
Natureworld

Factors determining survival in oligometastatic breast cancer in a retrospective cohort study from a low and middle income country

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE50OWZxamVoMVFtYUZLVmZRQW1wdEZFOF9XTDZIQW5CV3B6SzhpbDFQYUNyY2JlR04wN0xMMHhTVS1fb0FiS0xTZVlIRDVKcHJ3X0NGQ1JxbXNPTEhrY28w?oc=5" target="_blank">Factors determining survival in oligometastatic breast cancer in a retrospective cohort study from a low and middle income country</a>  <font color="#6f6f6f">Nature</font>

Breast Cancer Research Highlights from ASCO 2026
Breast Cancer.orggeneral

Breast Cancer Research Highlights from ASCO 2026

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFB5VnllQTBxSVdKbGxYekZIMGdNdnFPLTQ5eUhmZ0VnS09MOWZTZlQ1NFp6eEFjeFNKOHNQcTFNSGNWTGNIYl84dS02b091eXBpZ0lNNmFRMGRVMTloekJsdTRoX0NiNW1q?oc=5" target="_blank">Breast Cancer Research Highlights from ASCO 2026</a>  <font color="#6f6f6f">Breast Cancer.org</font>

Racial disparities in breast cancer subtypes, recurrence, and survival: a longitudinal cohort analysis
Frontiersgeneral

Racial disparities in breast cancer subtypes, recurrence, and survival: a longitudinal cohort analysis

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxORDM5WVk1b3hiZkR6bFRKVTB1X0FlSFhsT3R5YTJVR18tdUlPNFFpSzdXa3NYdHlPMlFmWUpXOGlvc1dNbXp1VFV1M0ctX0RuQlFuYUNMUVd4UDV3UTNIVXNsWjBFMXVUZXpyeWlBcnhjSXhPWl9nczVLa09KX0s0TkM3ZmVyZDBzbUppNC1R?oc=5" target="_blank">Racial disparities in breast cancer subtypes, recurrence, and survival: a longitudinal cohort analysis</a>  <font color="#6f6f6f">Frontiers</font>

No Survival Benefit With Mastectomy in Younger, High-Risk Breast Cancer
MedPage Todayworld

No Survival Benefit With Mastectomy in Younger, High-Risk Breast Cancer

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9EcTUzVkJOWUJDNUdDOXhNNlU1cW1KRHhidmlEWXBnbXI3eUlVUl9vY25YYzhjM0tZZlVBTmMwbGdEMUR0TEJxZEVhYXE3cU45dEx5c2NIVDhDOVI1WFdnb2RlRWFIaW9LU2pDSGxnbFVIWGx0dHc?oc=5" target="_blank">No Survival Benefit With Mastectomy in Younger, High-Risk Breast Cancer</a>  <font color="#6f6f6f">MedPage Today</font>

No Survival Dip After Skipping Axillary Surgery for Some Early Breast Cancers
MedPage Todaygeneral

No Survival Dip After Skipping Axillary Surgery for Some Early Breast Cancers

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1sZ0J6aWxlTzZhWVRMRElTVGhJZDdwTW5EVzlMQUMwUnJaeDBJbzlKOW1MVXo3eF9kZHdYLU9OckJEZ0lTeURqYmhiNC1iTk9wdGYtOFNyLVpvU2phVmZzaFRlSzIxTEk?oc=5" target="_blank">No Survival Dip After Skipping Axillary Surgery for Some Early Breast Cancers</a>  <font color="#6f6f6f">MedPage Today</font>

Differences in distant metastasis risk of breast cancer originating from various primary sites: a retrospective analysis based on the SEER database
Naturegeneral

Differences in distant metastasis risk of breast cancer originating from various primary sites: a retrospective analysis based on the SEER database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB0WWlHUEJTUlB5RzFpS0MyVHFsVTRyQ1RBSW9EdkhhRUxLaE5qbGlDeWRNZEdGekxjU0NrU2tKMVVtUVFIbkIwQkVsNkVMSVNKbGVLNkE2OGRWYUVuTUZr?oc=5" target="_blank">Differences in distant metastasis risk of breast cancer originating from various primary sites: a retrospective analysis based on the SEER database</a>  <font color="#6f6f6f">Nature</font>

Pathologic Complete Response Still Matters in Early HER2-Positive and Triple-Negative Breast Cancer, but Residual Disease Tells the Real Prognostic Story
Oncodailygeneral

Pathologic Complete Response Still Matters in Early HER2-Positive and Triple-Negative Breast Cancer, but Residual Disease Tells the Real Prognostic Story

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1mT0ZNRDNYeVBHNmg4RGY1T0NVMzZwTUxpWE5CZ2lfZ3p2ekxKVFhpTmRmY19CdmpyNkRYYjlHcDJmb2QxMU1ZWnJuN2JuYm9LeWNwbGJwOW9LWUxXckFXZGYxTy03ZmNJUVR2ekpTYw?oc=5" target="_blank">Pathologic Complete Response Still Matters in Early HER2-Positive and Triple-Negative Breast Cancer, but Residual Disease Tells the Real Prognostic Story</a>  <font color="#6f6f6f">Oncodaily</font>

IM-MS Irradiation Reduced Breast Cancer Mortality but Did Not Improve Overall Survival in Node-Negative Breast Cancer
Oncodailygeneral

IM-MS Irradiation Reduced Breast Cancer Mortality but Did Not Improve Overall Survival in Node-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBobS1UTXFFRERFaldIZWV5aWYzbHU4REpMdFBEN1dfb3dyNGZWN19GMjhjaXZhRmxZdV9OdVZRXzBLWFNSdkc3VThPMHJRYTdZRms5WkxPMURRSXhHYWV3OEs3aV9xdDlUUnVEbmNfTnYxQjJOYkE?oc=5" target="_blank">IM-MS Irradiation Reduced Breast Cancer Mortality but Did Not Improve Overall Survival in Node-Negative Breast Cancer</a>  <font color="#6f6f6f">Oncodaily</font>

Redlining Linked to Breast Cancer Survival Gaps: Sarah M. Lima, PhD, MPH
The American Journal of Managed Caregeneral

Redlining Linked to Breast Cancer Survival Gaps: Sarah M. Lima, PhD, MPH

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPYlRFam1za2Y0Tjhfd256dlVWdzRueGNrUVJDMzlhQTB6ckM4YUw1eFFuYUNCeEY5eHYtYmVoek9xYVBSamRYMW04WXEzX2tnMURMV2VBSG9oaFh2WlRDcW9sSHFaa0Y4ODNuVGlLR3ZUcmNLcXNORXB3bTBsMERSOXhtNFQtV0RNbDIzY1RoQkQ3RWdaV2lLWTBn?oc=5" target="_blank">Redlining Linked to Breast Cancer Survival Gaps: Sarah M. Lima, PhD, MPH</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Impact of estrogen receptor expression levels on chemo-responsiveness and prognosis of breast cancer patients treated with neoadjuvant chemotherapy | npj Breast Cancer
Naturegeneral

Impact of estrogen receptor expression levels on chemo-responsiveness and prognosis of breast cancer patients treated with neoadjuvant chemotherapy | npj Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1PWkpGc3kxUGU5eG1mUkpnR3hqczMxQkl3djl6R2lPbGg4WkFHZkpsU2NzTEQyTjVHdDYzRC1jRktYZ3lsa2hYMXZkb05BU281b19rR2VYTHRZTnFHdXVB?oc=5" target="_blank">Impact of estrogen receptor expression levels on chemo-responsiveness and prognosis of breast cancer patients treated with neoadjuvant chemotherapy | npj Breast Cancer</a>  <font color="#6f6f6f">Nature</font>

Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
AstraZenecaworld

Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxPUjdseWhyQnRzd1NZS2huSmFKU0ZyZjZpZThGaU9DRlpPbF95dkk3SjBZdkpCdnZlZ205WWJwMERpaU1OenZoem00VFBYWU04VWRGNFl0bGMxakoyOUoyX2lkbDFtVFItRkppb1QtY0VuM3BWdWMtRE9qRk1BQUtNMlJoNWVHejJNOXE3NVo1TlRPeWtYazFNa0s2Zy1BWnhSVGtjdUE0T3RjZGdJYncwY2dpNzE1ZEJtOHZ4eFV2U2Y4eGRZVG5pdUNBam9YczhJUW9ZYXRybGppZmc?oc=5" target="_blank">Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy</a>  <font color="#6f6f6f">AstraZeneca</font>

Key Takeaways From SABCS 2025
Breast Cancer.orggeneral

Key Takeaways From SABCS 2025

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE05WHA2ZUMwMXFYWFg5RDd0a2FKRzdsbmd3U25VUzdXSnc4UjU2akJ0SFhnb0MtblpDYmVVRy1IX1l5Q2lsc1lwWlp1TWlSVEx3Y0tqSkk2OFJxdUJHbDhNd25qcGVEdw?oc=5" target="_blank">Key Takeaways From SABCS 2025</a>  <font color="#6f6f6f">Breast Cancer.org</font>

"Breast Cancer Survival No" — Live Google News Trends & Headlines